BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 22888169)

  • 41. Amniotic fluid antiphospholipid antibodies: potential role in antiphospholipid syndrome-independent aberrant implantation process.
    Bruno V; Nuccetelli M; Ticconi C; Bruno A; Martelli F; Capogna MV; Bernardini S; Piccione E; Pietropolli A
    Reprod Biol Endocrinol; 2019 Oct; 17(1):79. PubMed ID: 31615575
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risky business: the interpretation, use, and abuse of antiphospholipid antibody tests in clinical practice.
    Roubey RA
    Lupus; 2010 Apr; 19(4):440-5. PubMed ID: 20353985
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J; Cabral AR; Alarcón-Segovia D
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of anti-β2-GPI antibodies on cytokine production in normal first-trimester trophoblast cells.
    Azuma H; Yamamoto T; Chishima F
    J Obstet Gynaecol Res; 2016 Jul; 42(7):769-75. PubMed ID: 27098191
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathogenic role of anti-beta 2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of beta 2-glycoprotein I binding to trophoblast cells and functional effects of anti-beta 2-glycoprotein I antibodies in vitro.
    Di Simone N; Raschi E; Testoni C; Castellani R; D'Asta M; Shi T; Krilis SA; Caruso A; Meroni PL
    Ann Rheum Dis; 2005 Mar; 64(3):462-7. PubMed ID: 15256379
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of a Monoclonal Antibody That Attenuates Antiphospholipid Syndrome-Related Pregnancy Complications and Thrombosis.
    Mineo C; Lanier L; Jung E; Sengupta S; Ulrich V; Sacharidou A; Tarango C; Osunbunmi O; Shen YM; Salmon JE; Brekken RA; Huang X; Thorpe PE; Shaul PW
    PLoS One; 2016; 11(7):e0158757. PubMed ID: 27463336
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of women with recurrent pregnancy losses and antiphospholipid antibody syndrome.
    Kwak-Kim J; Agcaoili MS; Aleta L; Liao A; Ota K; Dambaeva S; Beaman K; Kim JW; Gilman-Sachs A
    Am J Reprod Immunol; 2013 Jun; 69(6):596-607. PubMed ID: 23521391
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Beta 2 glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome.
    La Rosa L; Meroni PL; Tincani A; Balestrieri G; Faden D; Lojacono A; Morassi L; Brocchi E; Del Papa N; Gharavi A
    J Rheumatol; 1994 Sep; 21(9):1684-93. PubMed ID: 7799350
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-phospholipid antibodies increase non-apoptotic trophoblast shedding: a contribution to the pathogenesis of pre-eclampsia in affected women?
    Chen Q; Viall C; Kang Y; Liu B; Stone P; Chamley L
    Placenta; 2009 Sep; 30(9):767-73. PubMed ID: 19631379
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of an Fc gamma receptor-independent mechanism by which intravenous immunoglobulin ameliorates antiphospholipid antibody-induced thrombogenic phenotype.
    Pierangeli SS; Espinola R; Liu X; Harris EN; Salmon JE
    Arthritis Rheum; 2001 Apr; 44(4):876-83. PubMed ID: 11315927
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunoglobulins from sera of antiphospholipid syndrome patients are internalized in the HTR-8/SVneo cell line and cytotrophoblast in culture.
    Jovanović Krivokuća M; Stefanoska I; Abu Rabi T; Marković M; Janković S; Vrzić-Petronijević S; Vićovac L
    Immunobiology; 2018 Oct; 223(10):544-548. PubMed ID: 29960807
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation.
    Girardi G; Redecha P; Salmon JE
    Nat Med; 2004 Nov; 10(11):1222-6. PubMed ID: 15489858
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monoclonal antibody 26 cross-reactive with β2-glycoprotein I affects human trophoblast invasion in vitro.
    Kovačević TM; Radojčić L; Tošić NM; Pavlović ST; Vićovac LM
    Eur J Obstet Gynecol Reprod Biol; 2013 Nov; 171(1):23-9. PubMed ID: 24012450
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of 139 pregnancies in antiphospholipid-positive women not fulfilling criteria for antiphospholipid syndrome: a retrospective study.
    Del Ross T; Ruffatti A; Visentin MS; Tonello M; Calligaro A; Favaro M; Hoxha A; Punzi L
    J Rheumatol; 2013 Apr; 40(4):425-9. PubMed ID: 23418380
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism.
    Rand JH; Wu XX; Andree HA; Lockwood CJ; Guller S; Scher J; Harpel PC
    N Engl J Med; 1997 Jul; 337(3):154-60. PubMed ID: 9219701
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcomes and treatment of obstetrical antiphospholipid syndrome in women with low antiphospholipid antibody levels.
    Mekinian A; Loire-Berson P; Nicaise-Roland P; Lachassinne E; Stirnemann J; Boffa MC; Chollet-Martin S; Carbillon L; Fain O
    J Reprod Immunol; 2012 Jun; 94(2):222-6. PubMed ID: 22386067
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathogenesis of antiphospholipid antibodies: impairment of fibrinolysis and monocyte activation via the p38 mitogen-activated protein kinase pathway.
    Yasuda S; Bohgaki M; Atsumi T; Koike T
    Immunobiology; 2005; 210(10):775-80. PubMed ID: 16325497
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interleukin-6 stimulates cell migration, invasion and integrin expression in HTR-8/SVneo cell line.
    Jovanović M; Vićovac L
    Placenta; 2009 Apr; 30(4):320-8. PubMed ID: 19251319
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of ras by farnesylthiosalicylate significantly reduces the levels of autoantibodies in two animal models of the antiphospholipid syndrome.
    Katzav A; Kloog Y; Korczyn AD; Molina V; Blank M; Shoenfeld Y; Chapman J
    Immunobiology; 2003; 207(1):47-50. PubMed ID: 12638903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.